482 research outputs found
Tight-binding study of high-pressure phase transitions in titanium: alpha to omega and beyond
We use a tight-binding total energy method, with parameters determined from a
fit to first-principles calculations, to examine the newly discovered gamma
phase of titanium. Our parameters were adjusted to accurately describe the
alpha Ti-omega Ti phase transition, which is misplaced by density functional
calculations. We find a transition from omega Ti to gamma Ti at 102 GPa, in
good agreement with the experimental value of 116 GPa. Our results suggest that
current density functional calculations will not reproduce the omega Ti-gamma
Ti phase transition, but will instead predict a transition from omega Ti to the
bcc beta Ti phase.Comment: 3 encapsulated Postscript figures, submitted to Phyical Review
Letter
Kaon production in heavy-ion collisions and maximum mass of neutron stars
We determine an `empirical' kaon dispersion relation by analysing and fitting
recent experimental data on kaon production in heavy-ion collisions. We then
investigate its effects on hadronic equation of state at high densities and on
neutron star properties. We find that the maximum mass of neutron stars can be
lowered by about 0.4, once kaon condensation as constrained by our
empirical dispersion relation is introduced. We emphasize the growing interplay
between hadron physics, relativistic heavy-ion physics and the physics of
compact objects in astrophysics.Comment: 6 pages with 3 postscript figures, to appear in Physical Review
Letter
Co-Evolution of quasispecies: B-cell mutation rates maximize viral error catastrophes
Co-evolution of two coupled quasispecies is studied, motivated by the
competition between viral evolution and adapting immune response. In this
co-adaptive model, besides the classical error catastrophe for high virus
mutation rates, a second ``adaptation-'' catastrophe occurs, when virus
mutation rates are too small to escape immune attack. Maximizing both regimes
of viral error catastrophes is a possible strategy for an optimal immune
response, reducing the range of allowed viral mutation rates to a minimum. From
this requirement one obtains constraints on B-cell mutation rates and receptor
lengths, yielding an estimate of somatic hypermutation rates in the germinal
center in accordance with observation.Comment: 4 pages RevTeX including 2 figure
Photon and dilepton emission rates from high density quark matter
We compute the rates of real and virtual photon (dilepton) emission from
dense QCD matter in the color-flavor locked (CFL) phase, focusing on results at
moderate densities (3-5 times the nuclear saturation density) and temperatures
MeV. We pursue two approaches to evaluate the electromagnetic
(e.m.) response of the CFL ground state: (i) a direct evaluation of the photon
self energy using quark particle/-hole degrees of freedom, and (ii) a Hidden
Local Symmetry (HLS) framework based on generalized mesonic excitations where
the meson is introduced as a gauge boson of a local SU(3) color-flavor
group. The coupling to generalized two-pion states induces a finite
width and allows to address the issue of vector meson dominance (VMD) in the
CFL phase. We compare the calculated emissivities (dilepton rates) to those
arising from standard hadronic approaches including in-medium effects. For
rather large superconducting gaps (several tens of MeV at moderate densities),
as suggested by both perturbative and nonperturbative estimates, the dilepton
rates from CFL quark matter turn out to be very similar to those obtained in
hadronic many-body calculations, especially for invariant masses above
GeV. A similar observation holds for (real) photon production.Comment: 18 pages, 12 figure
Heterogeneity of quality of life in young people attending primary mental health services
AIMS: The utility of quality of life (QoL) as an outcome measure in youth-specific primary mental health care settings has yet to be determined. We aimed to determine: (i) whether heterogeneity on individual items of a QoL measure could be used to identify distinct groups of help-seeking young people; and (ii) the validity of these groups based on having clinically meaningful differences in demographic and clinical characteristics. METHODS: Young people, at their first presentation to one of five primary mental health services, completed a range of questionnaires, including the Assessment of Quality of Lifeâ6 dimensions adolescent version (AQoL-6D). Latent class analysis (LCA) and multivariate multinomial logistic regression were used to define classes based on AQoL-6D and determine demographic and clinical characteristics associated with class membership. RESULTS: 1107 young people (12â25 years) participated. Four groups were identified: (i) no-to-mild impairment in QoL; (ii) moderate impairment across dimensions but especially mental health and coping; (iii) moderate impairment across dimensions but especially on the pain dimension; and (iv) poor QoL across all dimensions along with a greater likelihood of complex and severe clinical presentations. Differences between groups were observed with respect to demographic and clinical features. CONCLUSIONS: Adding multi-attribute utility instruments such as the AQoL-6D to routine data collection in mental health services might generate insights into the care needs of young people beyond reducing psychological distress and promoting symptom recovery. In young people with impairments across all QoL dimensions, the need for a holistic and personalised approach to treatment and recovery is heightened
A participatory intervention to improve the mental health of widows of injecting drug users in north-east India as a strategy for HIV prevention
BACKGROUND: Manipur and Nagaland, in the north-east of India, are classified as high prevalence states for HIV, and intravenous drug use is an important route of transmission. Most injecting drug users (IDUs) are men, an estimated 40% are married, and death rates have been high in the last five years, consequently the number of widows of IDUs has increased. Many of these widows and their children are HIV-infected and experience poor health, discrimination, and impoverishment; all factors likely to be compromising their mental health. People with poor mental health are more likely to engage in HIV risk behaviours. Mental health can be promoted by public health actions with vulnerable population groups. METHODS: We designed an intervention study to assess the feasibility and impact of a participatory action process to promote the mental health and well-being of widows of IDUs in Manipur and Nagaland, as a strategy for reducing the risk of engagement in HIV risk behaviours. This paper describes the background and rationale for the study, the intervention, and the study methods in detail. RESULTS: Pending analysis. CONCLUSION: This intervention study will make a significant contribution to the emerging evidence that supports associations between mental health and HIV. The concept of promoting mental health among women who are vulnerable to HIV infection or already infected as a strategy for HIV prevention in a development setting is breaking new ground
Recommended from our members
No straight lines â young womenâs perceptions of their mental health and wellbeing during and after pregnancy: a systematic review and meta-ethnography
Background: Young mothers face mental health challenges during and after pregnancy including increased rates of depression compared to older mothers. While the prevention of teenage pregnancy in countries such as the United States and the United Kingdom has been a focus for policy and research in recent decades, the need to understand young womenâs own experiences has been highlighted. The aim of this meta-ethnography was to examine young womenâs perceptions of their mental health and wellbeing during and after pregnancy to provide new understandings of those experiences.
Methods: A systematic review and meta-ethnographic synthesis of qualitative research was conducted. Seven databases were systematically searched and forward and backward searching conducted. Papers were included if they were from Organisation for Economic Co-operation and Development countries and explored mental health and wellbeing experiences of young mothers (age under 20 in pregnancy; under 25 at time of research) as a primary research question â or where evidence about mental health and wellbeing from participants was foregrounded. Nineteen papers were identified and the Critical Appraisal Skills Programme checklist for qualitative research used to appraise the evidence. Following the seven-step process of meta-ethnography, key constructs were examined within each study and then translated into one another.
Results: Seven translated themes were identified forming a new line of argument wherein mental health and wellbeing was analysed as relating to individual bodily experiences; tied into past and present relationships; underpinned by economic insecurity and entangled with feelings of societal surveillance. There were âno straight linesâ in young womenâs experiences, which were more complex than dominant narratives around overcoming adversity suggest.
Conclusions: The synthesis concludes that health and social care professionals need to reflect on the operation of power and stigma in young womenâs lives and its impact on wellbeing. It adds to understanding of young womenâs mental health and wellbeing during and after pregnancy as located in physical and structural factors rather than individual capacities alone
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial
IMPORTANCE: Secretory phospholipase A2(sPLA2) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown. OBJECTIVE: To determine the effects of sPLA2inhibition with varespladib on cardiovascular outcomes. DESIGN, SETTING, AND PARTICIPANTS: A double-blind, randomized, multicenter trial at 362 academic and community hospitals in Europe, Australia, New Zealand, India, and North America of 5145 patients randomized within 96 hours of presentation of an acute coronary syndrome (ACS) to either varespladib (n = 2572) or placebo (n = 2573) with enrollment between June 1, 2010, and March 7, 2012 (study termination on March 9, 2012). INTERVENTIONS: Participants were randomized to receive varespladib (500 mg) or placebo daily for 16 weeks, in addition to atorvastatin and other established therapies. MAIN OUTCOMES AND MEASURES: The primary efficacy measurewas a composite of cardiovascular mortality, nonfatal myocardial infarction (MI), nonfatal stroke, or unstable angina with evidence of ischemia requiring hospitalization at 16 weeks. Six-month survival status was also evaluated. RESULTS: At a prespecified interim analysis, including 212 primary end point events, the independent data and safety monitoring board recommended termination of the trial for futility and possible harm. The primary end point occurred in 136 patients (6.1%) treated with varespladib compared with 109 patients (5.1%) treated with placebo (hazard ratio [HR], 1.25; 95%CI, 0.97-1.61; log-rank P = .08). Varespladib was associated with a greater risk of MI (78 [3.4%] vs 47 [2.2%]; HR, 1.66; 95%CI, 1.16-2.39; log-rank P = .005). The composite secondary end point of cardiovascular mortality, MI, and stroke was observed in 107 patients (4.6%) in the varespladib group and 79 patients (3.8%) in the placebo group (HR, 1.36; 95% CI, 1.02-1.82; P = .04). CONCLUSIONS AND RELEVANCE: In patients with recent ACS, varespladib did not reduce the risk of recurrent cardiovascular events and significantly increased the risk of MI. The sPLA2inhibition with varespladib may be harmful and is not a useful strategy to reduce adverse cardiovascular outcomes after ACS. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01130246. Copyright 2014 American Medical Association. All rights reserved
The association between intimate partner violence, alcohol and depression in family practice
Background: Depressive symptoms, intimate partner violence and hazardous drinking are common among patients attending general practice. Despite the high prevalence of these three problems; the relationship between them remains relatively unexplored.
Methods: This paper explores the association between depressive symptoms, ever being afraid of a partner and hazardous drinking using cross-sectional screening data from 7667 randomly selected patients from a large primary care cohort study of 30 metropolitan and rural general practices in Victoria, Australia. The screening postal survey included the Center for Epidemiological Studies Depression Scale, the Fast Alcohol Screening Test and a screening question from the Composite Abuse Scale on ever being afraid of any intimate partner.
Results: 23.9% met criteria for depressive symptoms. A higher proportion of females than males (20.8% vs. 7.6%) reported ever being afraid of a partner during their lifetime (OR 3.2, 95%CI 2.5 to 4.0) and a lower proportion of females (12%) than males (25%) were hazardous drinkers (OR 0.4; 95%CI 0.4 to 0.5); and a higher proportion of females than males (20.8% vs. 7.6%) reported ever being afraid of a partner during their lifetime (OR 3.2, 95%CI 2.5 to 4.0). Men and women who had ever been afraid of a partner or who were hazardous drinkers had on average higher depressive symptom scores than those who had never been afraid or who were not hazardous drinkers. There was a stronger association between depressive symptoms and ever been afraid of a partner compared to hazardous drinking for both males (ever afraid of partner; Diff 6.87; 95% CI 5.42, 8.33; p < 0.001 vs. hazardous drinking in last year; Diff 1.07, 95% CI 0.21, 1.94; p = 0.015) and females (ever afraid of partner; Diff 5.26; 95% CI 4.55, 5.97; p < 0.001 vs. hazardous drinking in last year; Diff 2.23, 95% CI 1.35, 3.11; p < 0.001), even after adjusting for age group, income, employment status, marital status, living alone and education level.
Conclusions: Strategies to assist primary care doctors to recognise and manage intimate partner violence and hazardous drinking in patients with depression may lead to better outcomes from management of depression in primary care
- âŠ